Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome

By sjmartinez • October 5, 2022

Gaylis NB, Ritter A, Kelly SA, Pourhassan NZ, Tiwary M, Sacha JB, Hansen SG, Recknor C, Yang OO. Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome. Clin Infect Dis. 2022 Sep 30;75(7):1232-1234. doi: 10.1093/cid/ciac226. PMID: 35452519; PMCID: PMC9383814.

Tags: CCR5, immunosuppression, Infectious Diseases, leronlimab, long COVID, Publications

Opioid agonist therapy adherence trajectories among commercially and publicly insured people living with Hepatitis C in the United States

Psaras C, Arah OA, Chew KW, Lee SJ, Javanbakht M, Nianogo RA, Seamans MJ. Opioid agonist therapy adherence trajectories among commercially and publicly insured people[...]

Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent Traveler in Belize and Guatemala

Ko MY, Fowler E, Scott A, Uslan DZ. Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent[...]

Libraries Burned, a Life Lived

Vijayan T. Libraries Burned, a Life Lived. N Engl J Med. 2025 Jul 5. doi: 10.1056/NEJMp2500746. Epub ahead of print. PMID: 40621845.